NADAC acquisition cost data for PNV 29-1 TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
| 69543026790 | $0.2824 | 2021-07-21 | Rx |
Generic: PNV No.163/Iron/Folate No.10 | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | $65.7K | 26 | 17 | $34.24 |
| 2022 | $125.6K | 56 | 24 | $34.61 |
| 2023 | $72.9K | 31 | N/A | $34.23 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.